U.S. Markets closed

Alexion Pharmaceuticals: What to Expect from Its Q3 Earnings

Kenneth Smith
Alexion Pharmaceuticals: What to Expect from Its Q3 Earnings

Alexion Pharmaceuticals (ALXN) is scheduled to report its third-quarter earnings on October 24. Analysts expect Alexion Pharmaceuticals’ revenues to increase 18.45% from $859.0 million in the third quarter of 2017 to $1.02 billion in the third quarter. For 2018 and 2019, Alexion Pharmaceuticals is expected to generate revenues of $4.04 billion and $4.72 billion, respectively.